P
Philippe Moreau
Researcher at University of Nantes
Publications - 693
Citations - 52995
Philippe Moreau is an academic researcher from University of Nantes. The author has contributed to research in topics: Multiple myeloma & Medicine. The author has an hindex of 104, co-authored 517 publications receiving 42530 citations. Previous affiliations of Philippe Moreau include University of Grenoble & National and Kapodistrian University of Athens.
Papers
More filters
Journal ArticleDOI
S173: t-cell activation and myeloma cell killing confirm the mode of action of rg6234, a novel gprc5d t-cell engaging bispecific antibody, in patients with relapsed/refractory multiple myeloma
Iryna Dekhtiarenko,Iva Lelios,Jan Attig,Nassim Sleiman,Domenico Lazzaro,Ida Clausen,Nicole Gräfe,Hans-Joachim Helms,E. Schindler,Sara Belli,Tanja Fauti,R. Eckmann,Pablo Umana,Wolfgang Jacob,Min Jeong Schneider,Caroline Hasselbalch Riley,Martin Hutchings,S.-S. Yoon,Y Koh,Salomon Manier,Thierry Facon,Simon J. Harrison,J. Er,Francesco Volzone,Antonietta Pinto,Constantino Ledesma Montes,Enrique M. Ocio,Ana Alfonso-Pierola,P. Rodriguez Otero,Fritz Offner,Anna Guidetti,Paolo Corradini,C. Titouan,Cyrille Hulin,Cyrille Touzeau,Philippe Moreau,Rakesh Popat,Stephanie Leong,Rita Mazza,Carmelo Carlo-Stella,Ann-Marie Bröske +40 more
TL;DR: Riley et al. as mentioned in this paper presented preliminary clinical biomarker data highlighting PD effects after intravenous (IV) administration that confirm the mechanism of action and high potency of RG6234, which is a novel T-cell engaging bispecific antibody targeting G protein-coupled receptor 5D with a unique 2:1 format.
Journal ArticleDOI
Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma.
Maria-Victoria Mateos,Ajai Chari,Saad Z. Usmani,Hartmut Goldschmidt,Katja Weisel,Keqin Qi,Anil Londhe,Sandhya Nair,Xiwu Lin,Lixia Pei,Eric A. Ammann,Rachel Kobos,Jennifer Smit,Trilok V. Parekh,A. Marshall,Mary Slavcev,Philippe Moreau +16 more
TL;DR: In this paper , the efficacy and safety of teclistamab in patients with RRMM who received ≥3 prior lines of therapy and were triple-class exposed (TCE) are evaluated in the single-arm, multicohort, phase I/II MajesTEC-1 trial (NCT04557098).
Journal ArticleDOI
P956: emmy cohort: management of newly diagnosed or relapsed/ refractory multiple myeloma in patients aged of 80 years and over
Margaret Macro,Olivier Decaux,A. Perrot,Bruno Royer,M. L. Chretien,Karim Belhadj,Mohamad Mohty,Laurent Frenzel,Xavier Leleu,Mamoun Dib,Olivier Allangba,Patricia Zunic,I. Botoc,Jean-Valère Malfuson,Philippe Moreau,R. Garlantazec,Nogues Isabelle Texier,Raphaël Germain,Caitlyn Deal,Cyrille Hulin +19 more
TL;DR: The EMMY study is a large-scale epidemiological study to assess the epidemiology and real-life management of MM and can help improve the quality of life for patients with myeloma.
Journal ArticleDOI
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network.
Heinz Ludwig,Evangelos Terpos,N. W. C. J. van de Donk,Maria-Victoria Mateos,Philippe Moreau,Meletios A. Dimopoulos,Michel Delforge,Paula Rodriguez-Otero,Jesús F. San Miguel,Kwee Yong,Francesca Gay,Hermann Einsele,Roberto Mina,Jo Caers,Christoph Driessen,Pellegrino Musto,Sonja Zweegman,Monika Engelhardt,Gordon Cook,Katja Weisel,Annemiek Broijl,Meral Beksac,Jelena Bila,Fredrik Schjesvold,Michele Cavo,Roman Hájek,Cyrille Touzeau,Mario Boccadoro,Pieter Sonneveld +28 more
TL;DR: In this article , the authors present a consensus from the European Myeloma Network on the prevention and management of adverse events such as cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome (ICANS), cytopenias, hypogammaglobulinaemia, and infections.
Journal ArticleDOI
Coordinatively Cross-Linked Binders for Silicon-Based Electrodes for Li-Ion Batteries: Beneficial Impact on Mechanical Properties and Electrochemical Performance.
L. Huet,Driss Mazouzi,Philippe Moreau,Nicolas Dupré,Michael Paris,Sébastien Mittelette,Danielle Laurencin,Thomas Devic,Lionel Roué,Bernard Lestriez +9 more
TL;DR: In this article , a simple and versatile preparation of Zn(II)-poly(carboxylates) reticulated binders by the addition of preoptimized poly(Carboxylic acids) binder solution is proposed, which leads systematically to a significantly improved electrochemical performance when used for the formulation of silicon-based negative electrodes.